LONDON (Alliance News) - Physiomics PLC said Monday it has signed a further contract with a speciality pharmaceutical company, to be performed on a fee-for-service basis at its standard rate.
It did not disclose financial details of the contract. It is an extension to an existing contract Physiomics won with an undisclosed customer in December to perform pharmacokinetic/pharmacodynamic modelling analysis.
"We are delighted to have extended the PK/PD work we are performing for this new key customer. We hope to gain yet more business with this customer and similar clients in the future," said Chief Executive Mark Chadwick in a statement.
Shares in Physiomics were up 10% at 0.275 pence Monday.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Physiomics (PYC)